Further, in a preclinical model of glioblastoma, the Mer inhibitor UNC2025 results in induction of an inflammatory macrophage phenotype and reduced the fraction of TAMs expressing the anti-inflammatory marker CD206 in the tumor microenvironment (TME) (61). The gene discussed is MERTK; the disease is neoplasm.